A detailed history of Duncker Streett & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Duncker Streett & CO Inc holds 992 shares of NVS stock, worth $97,563. This represents 0.02% of its overall portfolio holdings.

Number of Shares
992
Previous 992 -0.0%
Holding current value
$97,563
Previous $105,000 8.57%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$92.57 - $107.37 $6,572 - $7,623
-71 Reduced 6.68%
992 $105,000
Q3 2022

Nov 04, 2022

SELL
$74.61 - $87.26 $12,683 - $14,834
-170 Reduced 13.79%
1,063 $81,000
Q1 2022

May 09, 2022

SELL
$80.11 - $90.62 $16,022 - $18,124
-200 Reduced 13.96%
1,233 $108,000
Q4 2021

Feb 08, 2022

SELL
$79.7 - $88.13 $23,910 - $26,439
-300 Reduced 17.31%
1,433 $125,000
Q2 2021

Jul 27, 2021

SELL
$85.24 - $94.15 $129,990 - $143,578
-1,525 Reduced 46.81%
1,733 $158,000
Q1 2021

Apr 28, 2021

SELL
$83.5 - $98.47 $127,755 - $150,659
-1,530 Reduced 31.95%
3,258 $278,000
Q4 2020

Feb 02, 2021

SELL
$78.07 - $94.43 $92,122 - $111,427
-1,180 Reduced 19.77%
4,788 $452,000
Q3 2020

Oct 28, 2020

SELL
$82.14 - $91.0 $18,892 - $20,930
-230 Reduced 3.71%
5,968 $519,000
Q1 2020

Apr 27, 2020

BUY
$70.67 - $99.01 $9,540 - $13,366
135 Added 2.23%
6,198 $511,000
Q4 2019

Jan 27, 2020

SELL
$84.35 - $95.37 $173,761 - $196,462
-2,060 Reduced 25.36%
6,063 $574,000
Q3 2019

Oct 31, 2019

SELL
$85.54 - $94.26 $45,934 - $50,617
-537 Reduced 6.2%
8,123 $706,000
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $30,537 - $37,584
-405 Reduced 4.47%
8,660 $791,000
Q4 2018

Jan 24, 2019

SELL
$73.66 - $82.02 $117,856 - $131,232
-1,600 Reduced 15.0%
9,065 $778,000
Q3 2018

Oct 22, 2018

BUY
$66.94 - $77.43 $33,470 - $38,715
500 Added 4.92%
10,665 $919,000
Q1 2018

Apr 26, 2018

BUY
$70.39 - $84.15 $63,351 - $75,735
900 Added 9.71%
10,165 $822,000
Q3 2017

Oct 25, 2017

BUY
$74.14 - $77.27 $686,907 - $715,906
9,265
9,265 $795,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Duncker Streett & CO Inc Portfolio

Follow Duncker Streett & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.